muscle mass loss glp 1 Glucagon-like peptide-1 receptor agonists and effects ▶️ GLP-1s don't destroy muscle.

doi: 10.3389/fimmu.2021.719023 132 KalraR

In a second double-blind RCT, KET 0.5 mg/kg IV bolus followed by a 30 min infusion of 0.25 mg/kg/h increased mood and serum brain-derived neurotrophic factor, which is a marker of major depressive disorders and treatment response (Jiang et al., 2016)

Keywords: Glucagon-like peptide-1 agonists, Osteoarthritis, Rheumatoid arthritis, Psoriatic arthritis, System lupus erythematosus, Inflammation Core Tip: Growing evidence suggests that glucagon-like peptide-1 and its receptor agonists could be an effective treatment option not only for metabolic disorders but also for a range of autoimmune and inflammatory diseases

People who are pregnant, breastfeeding or planning to become pregnant